Admin

Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children‘s Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9–11 November 2017, Rome, Italy

Author List
P Zangari
P Palma
N Cotugno
P Rojo
A Tagarro
I Pepponi
A De Rossi
L Kuhn
S Pahwa
M Cameron
E Nastouli
S Watters
AG Marceline
LE McCoy
D Persaud
A Violari
M Chan
AG Babiker
C Foster
J Ananworanich
C Giaquinto
P Rossi

Abstract

EPIICAL is a network of excellence concerned with a wide range of activities, including developmental research on novel disease modifying therapies (NDMTs), with the goal of achieving HIV remission. A central and timely theme of the network is the establishment of a predictive in vitro and in vivo platform to optimise the management of perinatally HIV-infected children and to inform treatment strategies. The EPIICAL project is a global collaboration of 27 international institutions, funded through an independent grant by ViiV Healthcare. Rome, Italy, hosted the first EPIICAL General Assembly (9–11 November 2017). Over 70 participants from 12 countries were brought together to discuss the updates of the first 18 months of the project, future strategies and perspectives.

Article Category

HIV cure research

Article Type

Conference report

Posted Date

02-01-2018

Tables & Figures

Back to top